# Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive

> **NCT00282581** · PHASE1 · TERMINATED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 2 (actual)

## Conditions studied

- HIV Infections
- Smallpox

## Interventions

- **BIOLOGICAL:** MVA Smallpox Vaccine

## Key facts

- **NCT ID:** NCT00282581
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Senior managemnt decision
- **Last updated:** 2014-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00282581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00282581, "Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00282581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*